In physician guided programs, these risks are monitored closely through symptom review, medical history screening, and ongoing follow up, making serious complications uncommon
None, except the FDA indication
The 10 secular trends highlighted in the Trends Shaping the Health Economy Report are supported by 100+ data stories, including: Cancer mortality is increasing for Americans ages 35-44, while decreasing for older age groups
Other studies show that Cotaduide could intervene and reverse NASH through improving metabolism in the liver including lipid and glucose metabolism via GCGR in mice, suggesting that Cotaduide may be a potential and viable therapeutic as a targeted drug intervention to reverse disease progression of NASH (131)
Clinical trials at therapeutic doses (5 to 15 mg) showed mean body weight reductions of 15% to over 20% over 72 weeks in participants with obesity, depending on dose
It has a very high concentration of GHK at 2% along with a blend of DMAE and PephaTight - both for tightening